BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Amarantus BioSciences, Inc.  

675 Almanor Avenue

Sunnyvale  California  94085  U.S.A.
Phone: 408-737-2734 Fax: 408-852-4427


SEARCH JOBS




Industry
Biotechnology






 Company News
Amarantus BioSciences, Inc. Submits Orphan Drug Designation Application To U.S. FDA For Treatment Of Retinal Artery Occlusion With Product Candidate MANF 12/19/2014 7:47:59 AM
Amarantus BioSciences, Inc. Announces Second Closing Of Series E Preferred Financing 12/19/2014 7:46:06 AM
Amarantus BioSciences, Inc. Appoints Elise Brownell, Ph.D., As Senior Vice President Of Operations And Project Management 12/11/2014 7:40:14 AM
Amarantus BioSciences, Inc. Appoints Renowned Drug Development Expert And Co-Founder Of Amgen (AMGN), Joseph Rubinfeld, Ph.D., To Its Board Of Directors 12/8/2014 8:37:52 AM
Amarantus BioSciences, Inc. Announces Positive Preclinical Data On The Effects Of MANF On Vision In A Model Of Retinitis Pigmentosa 11/25/2014 9:50:54 AM
Amarantus BioSciences, Inc. Reports Third Quarter 2014 Financial Results And Enters Into Strategic Preferred Financing 11/10/2014 7:44:32 AM
Amarantus BioSciences, Inc. Applies To FDA For MANF Orphan Drug Designation In Retinitis Pigmentosa 10/16/2014 7:53:16 AM
Amarantus BioSciences, Inc. Announces Positive LP-002 Data For Alzheimer's Blood Diagnostic Lympro Test® 10/9/2014 7:38:57 AM
Amarantus BioSciences, Inc. Investigator Presents Positive MANF Animal Data In Central Retinal Vein Occlusion And Glaucoma At The Targeting Ocular Disorders Conference 10/7/2014 7:48:05 AM
Amarantus BioSciences, Inc. Requests Pre-IND Feedback From FDA For Eltoprazine Phase 2ib Parkinson's Disease Levodopa-Induced Dyskinesia Clinical Trial 9/29/2014 1:11:40 PM
12345678910...